| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587234 | Diabetes Research and Clinical Practice | 2017 | 29 Pages |
Abstract
Based on this systematic review, TCPM may reduce the risk of progression to T2DM and increase the possibility of regression toward normoglycemia. As a result of the methodological drawbacks of the included studies, more rigorously designed RCTs are required to more reliably assess the efficacy of TCPM and long-term follow-up is needed before TCPM can be recommended for prediabetic patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Bing Pang, Feng-mei Lian, Xi-yan Zhao, Xue-min Zhao, De Jin, Yi-qun Lin, Yu-jiao Zheng, Qing Ni, Xiao-lin Tong,